BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31234835)

  • 1. Dysregulated expression of hypoxia-inducible factors augments myofibroblasts differentiation in idiopathic pulmonary fibrosis.
    Aquino-Gálvez A; González-Ávila G; Jiménez-Sánchez LL; Maldonado-Martínez HA; Cisneros J; Toscano-Marquez F; Castillejos-López M; Torres-Espíndola LM; Velázquez-Cruz R; Rodríguez VHO; Flores-Soto E; Solís-Chagoyán H; Cabello C; Zúñiga J; Romero Y
    Respir Res; 2019 Jun; 20(1):130. PubMed ID: 31234835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
    Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia and transforming growth factor β1 regulation of long non-coding RNA transcriptomes in human pulmonary fibroblasts.
    Senavirathna LK; Huang C; Pushparaj S; Xu D; Liu L
    Physiol Rep; 2020 Jan; 8(1):e14343. PubMed ID: 31925944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent.
    Roach KM; Wulff H; Feghali-Bostwick C; Amrani Y; Bradding P
    Respir Res; 2014 Dec; 15(1):155. PubMed ID: 25476248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis.
    Kirillov V; Siler JT; Ramadass M; Ge L; Davis J; Grant G; Nathan SD; Jarai G; Trujillo G
    Am J Pathol; 2015 Apr; 185(4):943-57. PubMed ID: 25660181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
    Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
    Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Hypoxia in the Transcriptomic Profile of Lung Fibroblasts from Idiopathic Pulmonary Fibrosis.
    Romero Y; Balderas-Martínez YI; Vargas-Morales MA; Castillejos-López M; Vázquez-Pérez JA; Calyeca J; Torres-Espíndola LM; Patiño N; Camarena A; Carlos-Reyes Á; Flores-Soto E; León-Reyes G; Sierra-Vargas MP; Herrera I; Luis-García ER; Ruiz V; Velázquez-Cruz R; Aquino-Gálvez A
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts.
    Newman DR; Sills WS; Hanrahan K; Ziegler A; Tidd KM; Cook E; Sannes PL
    J Histochem Cytochem; 2016 Feb; 64(2):99-111. PubMed ID: 26538547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis.
    Cigna N; Farrokhi Moshai E; Brayer S; Marchal-Somme J; Wémeau-Stervinou L; Fabre A; Mal H; Lesèche G; Dehoux M; Soler P; Crestani B; Mailleux AA
    Am J Pathol; 2012 Dec; 181(6):2126-37. PubMed ID: 23031257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.
    Bamberg A; Redente EF; Groshong SD; Tuder RM; Cool CD; Keith RC; Edelman BL; Black BP; Cosgrove GP; Wynes MW; Curran-Everett D; De Langhe S; Ortiz LA; Thorburn A; Riches DWH
    Am J Respir Crit Care Med; 2018 Oct; 198(7):914-927. PubMed ID: 29727583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.
    Pardo A; Selman M
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S417-S421. PubMed ID: 28005427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wilms' tumor 1 drives fibroproliferation and myofibroblast transformation in severe fibrotic lung disease.
    Sontake V; Kasam RK; Sinner D; Korfhagen TR; Reddy GB; White ES; Jegga AG; Madala SK
    JCI Insight; 2018 Aug; 3(16):. PubMed ID: 30135315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis.
    Kobayashi K; Araya J; Minagawa S; Hara H; Saito N; Kadota T; Sato N; Yoshida M; Tsubouchi K; Kurita Y; Ito S; Fujita Y; Takasaka N; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Kojima J; Shimizu K; Numata T; Kawaishi M; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    J Immunol; 2016 Jul; 197(2):504-16. PubMed ID: 27279371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β.
    Kottmann RM; Kulkarni AA; Smolnycki KA; Lyda E; Dahanayake T; Salibi R; Honnons S; Jones C; Isern NG; Hu JZ; Nathan SD; Grant G; Phipps RP; Sime PJ
    Am J Respir Crit Care Med; 2012 Oct; 186(8):740-51. PubMed ID: 22923663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation.
    Pedroza M; Le TT; Lewis K; Karmouty-Quintana H; To S; George AT; Blackburn MR; Tweardy DJ; Agarwal SK
    FASEB J; 2016 Jan; 30(1):129-40. PubMed ID: 26324850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hedgehog and Wnt/β-catenin system machinery mediate myofibroblast differentiation of LR-MSCs in pulmonary fibrogenesis.
    Chen X; Shi C; Cao H; Chen L; Hou J; Xiang Z; Hu K; Han X
    Cell Death Dis; 2018 May; 9(6):639. PubMed ID: 29844390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-specific expression of runt-related transcription factor 2 contributes to pulmonary fibrosis.
    Mümmler C; Burgy O; Hermann S; Mutze K; Günther A; Königshoff M
    FASEB J; 2018 Feb; 32(2):703-716. PubMed ID: 28986417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3K p110γ overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition.
    Conte E; Gili E; Fruciano M; Korfei M; Fagone E; Iemmolo M; Lo Furno D; Giuffrida R; Crimi N; Guenther A; Vancheri C
    Lab Invest; 2013 May; 93(5):566-76. PubMed ID: 23439433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis.
    Xie N; Tan Z; Banerjee S; Cui H; Ge J; Liu RM; Bernard K; Thannickal VJ; Liu G
    Am J Respir Crit Care Med; 2015 Dec; 192(12):1462-74. PubMed ID: 26284610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-210 promotes IPF fibroblast proliferation in response to hypoxia.
    Bodempudi V; Hergert P; Smith K; Xia H; Herrera J; Peterson M; Khalil W; Kahm J; Bitterman PB; Henke CA
    Am J Physiol Lung Cell Mol Physiol; 2014 Aug; 307(4):L283-94. PubMed ID: 24951777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.